BriaCell Therapeutics Corp. Share Price
NASDAQ: BCTX | Micro Cap$3.49
+$3.49 (--%) Last updated on 18 Nov, 2026 | 00:47 ISTBriaCell Therapeutics Corp. Stock Performance
BriaCell Therapeutics Corp. Share Price Chart
$3.37$3.58
L
H
BriaCell Therapeutics Corp. Quarterly Profit & Loss
All figures in USD
BriaCell Therapeutics Corp. Annual Profit & Loss
All figures in USD
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company developing targeted immunotherapies to transform cancer care. Its Bria-IMT targeted immunotherapy is being developed in combination with the immune checkpoint inhibitor Retifanlimab in a pivotal Phase 3 study in metastatic breast cancer. The Company's operations focus on the research and development of its immunotherapy product candidates and related supporting activities.
BriaCell Therapeutics Corp. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $3.20 | $3.50 | +14.94% |
Oct 2026 | $4.16 | $3.04 | -28.52% |
Sep 2026 | $3.63 | $4.26 | +13.90% |
Aug 2026 | $3.40 | $3.74 | +3.89% |
Jul 2026 | $3.40 | $3.60 | +10.60% |
Jun 2026 | $3.27 | $3.25 | -9.83% |
May 2026 | $4.25 | $3.61 | -13.64% |
Apr 2026 | $4.22 | $4.18 | -0.48% |
Mar 2026 | $3.69 | $4.20 | +10.82% |
Feb 2026 | $4.28 | $3.79 | -11.96% |
Jan 2026 | $7.06 | $4.30 | -39.71% |
Dec 2025 | $12.29 | $7.14 | -26.39% |